| 英文别名 |
6-[4-methyl-2-oxo-5-phenylmethoxycarbonyl-6-(4-phenylphenyl)-1,6-dihydropyrimidin-3-yl]hexanoic acid;1(2H)-PyriMidinehexanoic acid, 4-[1,1'-biphenyl]-4-yl-3,4-dihydro-6-Methyl-2-oxo-5-[(phenylMethoxy)carbonyl]-;116-9e;4-[1,1′-Biphenyl]-4-yl-3,4-dihydro-6-methyl-2-oxo-5-[(phenylmethoxy)carbonyl]-1(2H)-pyrimidinehexanoic acid;MLS000563636;GLXC-27835;4-[1,1'-Biphenyl]-4-yl-3,4-dihydro-6-methyl-2-oxo-5-[(phenylmethoxy)carbonyl]-1(2H)-Pyrimidinehexanoic acid;MAL2-11B;UPCMLD00WMAL2-11B;HY-116683;6-(4-([1,1'-Biphenyl]-4-yl)-5-((benzyloxy)carbonyl)-6-methyl-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)hexanoic acid;MS-29517;UPCMLD00WMAL2-11B:003;DA-59835;1(2H)-Pyrimidinehexanoicacid,4-[1,1'-biphenyl]-4-yl-3,4-dihydro-6-methyl-2-oxo-5-[(phenylmethoxy)carbonyl]-;GLXC-04116;AKOS040747130;UPCMLD00WMAL2-11B:002;HMS2227G12;CMLD4_000072;831217-43-7;CS-0066274;116-9e, >=98% (HPLC), powder;DTXSID30420131;MAL2-11B (116-9e);NCGC00485182-01;SDCCGMLS-0091265.P001;DNAJA1 inhibitor 116-9e;CHEMBL411666;F17964;SMR000388845;MLS003180886;HMS3334E11;UPCMLD00WMAL2-11B:004 |